The H1N1 (Swine Flu) Vaccination Market was valued at USD 3.54 billion in 2023 and is projected to grow significantly, reaching USD 6.14 billion by 2032, at a CAGR of 6.32% over the forecast period from 2024 to 2032. This expansion is driven by increasing awareness of seasonal and pandemic flu outbreaks, growing investments in vaccine development, and...